ERFO Share Price Performance
€1.23
0.18 (16.59%)
Price €1.23
Share Price€1.23
ERFO Community Narratives
There are no narratives available yet.
Recent ERFO News & Updates
No updates
Laboratorio Farmaceutico Erfo S.p.A. Key Details
Last Reported Earnings
Dec 31, 2024
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- 0.041
- Gross Margin
- 42.07%
- Net Profit Margin
- 5.85%
- Debt/Equity Ratio
- 5.1%
Laboratorio Farmaceutico Erfo S.p.A. Competitors
About ERFO
- Founded
- 2013
- Employees
- 41
- CEO
- WebsiteView website
Laboratorio Farmaceutico Erfo S.p.A. engages in the formulation and production of food supplements in Italy. It produces various types of pharmaceutical forms, such as bottles, single-dose vials and bottles, capsules, tablets, and sachets under the Diètnatural and Gianopharma brands, as well as private label brands. The company offers custom formula creation, regulatory advice, graphics, and packaging services. The company was founded in 2013 and is based in Villafranca Tirrena, Italy.
Italian Market Performance
- 7 Days: -1.1%
- 3 Months: 4.7%
- 1 Year: 26.2%
- Year to Date: 17.3%
Over the last 7 days, the market has dropped 1.1%, driven by a decline of 7.9% in the Consumer Discretionary sector. As for the longer term, the market has actually risen by 28% in the last year. Earnings are forecast to grow by 8.3% annually. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading